On November 15, 2018, the Ministry of Health of Tunisia signed a Memorandum of Understanding with the World Federation of Hemophilia (WFH) providing a framework in which to consolidate their collaboration under the WFH Global Alliance for Progress (GAP) Second Decade Program from 2018 to 2020. The Memorandum of Understanding was signed by Alain Weill, President of the WFH, and Nabila Kaddour, Regional Director of Health from the Tunisian Ministry of Health.
The Tunisian Hemophilia Association (THA) joined the WFH in 1981, and since then, a collaborative relationship between those organizations and the Tunisian medical community has grown ever stronger. Tunisia was enrolled in the WFH GAP First Decade Program from 2007 to 2012, and the program has helped achieve sustainable improvements in the country in the diagnosis of people with hemophilia, in treatment and in care received. A separate hemophilia treatment unit was established at the Aziza Othmana Hospital, and bleeding disorders care was introduced in cities outside of the capital.
The Tunisian Government has supported hemophilia patients since 2007 and signed a first Memorandum of Understanding with the WFH in February 2008. Now—exactly a decade later—the Ministry of Health is reiterating its support to people with inherited bleeding disorders with a new agreement that provides the foundation to implement the GAP Second Decade Program in Tunisia. The overall objective of the program is to maintain the consolidated efforts of the government, the THA, local medical experts and the WFH, in order to both strengthen the national hemophilia care program and further improve hemophilia care delivery in Tunisia.
The GAP Program is supported by funding from: Bayer, Biotest, CSL Behring, Kedrion, Pfizer, Sanofi Genzyme, Shire, and SOBI. The WFH would also like to thank the World Health Organization for its support of the Program.